These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8573980)

  • 21. Sivelestat reduces inflammatory mediators and preserves neutrophil deformability during simulated extracorporeal circulation.
    Matsuzaki K; Hiramatsu Y; Homma S; Sato S; Shigeta O; Sakakibara Y
    Ann Thorac Surg; 2005 Aug; 80(2):611-7. PubMed ID: 16039215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beating heart revascularization with or without cardiopulmonary bypass: evaluation of inflammatory response in a prospective randomized study.
    Wan IY; Arifi AA; Wan S; Yip JH; Sihoe AD; Thung KH; Wong EM; Yim AP
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1624-31. PubMed ID: 15173716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukocyte filter enhances neutrophil activation during combined aortic valve and coronary artery bypass surgery.
    Koskenkari JK; Rimpiläinen J; Ohman H; Surcel HM; Vainionpää V; Biancari F; Ala-Kokko T; Juvonen T
    Heart Surg Forum; 2006; 9(4):E693-9. PubMed ID: 16844623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung dysfunction following cardiopulmonary bypass.
    Apostolakis E; Filos KS; Koletsis E; Dougenis D
    J Card Surg; 2010; 25(1):47-55. PubMed ID: 19549041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hybrid artificial lung with interleukin-10 and endothelial constitutive nitric oxide synthase gene-transfected endothelial cells attenuates inflammatory reactions induced by cardiopulmonary bypass.
    Ohata T; Sawa Y; Takagi M; Inoue T; Yoshida T; Kogaki S; Matsuda H
    Circulation; 1998 Nov; 98(19 Suppl):II269-74. PubMed ID: 9852913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perflubron emulsion reduces inflammation during extracorporeal circulation.
    McDonagh P; Cerney K; Hokama J; Lai G; Gonzales R; Davis-Gorman G; Copeland J
    J Surg Res; 2001 Jul; 99(1):7-16. PubMed ID: 11421598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxygen free radicals and the systemic inflammatory response.
    Closa D; Folch-Puy E
    IUBMB Life; 2004 Apr; 56(4):185-91. PubMed ID: 15230345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Addition of dextran sulfate to blood cardioplegia attenuates reperfusion injury in a porcine model of cardiopulmonary bypass.
    Banz Y; Rieben R; Zobrist C; Meier P; Shaw S; Lanz J; Carrel T; Berdat P
    Eur J Cardiothorac Surg; 2008 Sep; 34(3):653-60. PubMed ID: 18572413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using a miniaturized circuit and an asanguineous prime to reduce neutrophil-mediated organ dysfunction following infant cardiopulmonary bypass.
    Karamlou T; Schultz JM; Silliman C; Sandquist C; You J; Shen I; Ungerleider RM
    Ann Thorac Surg; 2005 Jul; 80(1):6-13; discussion 13-4. PubMed ID: 15975331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass.
    Shernan SK; Fitch JC; Nussmeier NA; Chen JC; Rollins SA; Mojcik CF; Malloy KJ; Todaro TG; Filloon T; Boyce SW; Gangahar DM; Goldberg M; Saidman LJ; Mangano DT;
    Ann Thorac Surg; 2004 Mar; 77(3):942-9; discussion 949-50. PubMed ID: 14992903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inflammatory response to cardiopulmonary bypass.
    Miller BE; Levy JH
    J Cardiothorac Vasc Anesth; 1997 May; 11(3):355-66. PubMed ID: 9161905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inflammatory response to cardiopulmonary bypass: part 1--mechanisms of pathogenesis.
    Warren OJ; Smith AJ; Alexiou C; Rogers PL; Jawad N; Vincent C; Darzi AW; Athanasiou T
    J Cardiothorac Vasc Anesth; 2009 Apr; 23(2):223-31. PubMed ID: 18930659
    [No Abstract]   [Full Text] [Related]  

  • 33. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies.
    Wan S; LeClerc JL; Vincent JL
    Chest; 1997 Sep; 112(3):676-92. PubMed ID: 9315800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The inflammatory response and extracorporeal circulation.
    Royston D
    J Cardiothorac Vasc Anesth; 1997 May; 11(3):341-54. PubMed ID: 9161904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil activation during cardiopulmonary bypass.
    Finn A; Rebuck N; Moat N
    J Thorac Cardiovasc Surg; 1992 Dec; 104(6):1746-8. PubMed ID: 1453741
    [No Abstract]   [Full Text] [Related]  

  • 36. Neutrophil protease enzymes and oxygen free radicals as mediators of pulmonary membrane damage.
    Westaby S
    Prog Clin Biol Res; 1987; 236A():75-86. PubMed ID: 3649822
    [No Abstract]   [Full Text] [Related]  

  • 37. Lung injury after cardiopulmonary bypass.
    Clark SC
    Perfusion; 2006 Jul; 21(4):225-8. PubMed ID: 16939116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of internal mediators in surgical stress].
    Endo S; Sato N
    Nihon Geka Gakkai Zasshi; 2003 Dec; 104(12):811-5. PubMed ID: 14733162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invited letter concerning: neutrophil activation during cardiopulmonary bypass.
    Dreyer WJ; Smith CW; Entman ML
    J Thorac Cardiovasc Surg; 1991 Aug; 102(2):318-20. PubMed ID: 1865704
    [No Abstract]   [Full Text] [Related]  

  • 40. Endothelial cells and inflammation.
    Ryan US; Ryan JW
    Clin Lab Med; 1983 Dec; 3(4):577-99. PubMed ID: 6360500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.